PTC Therapeutics | PTCT - Market Capitalization


PTC Therapeutics reported $5.74B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 185.28B 33.35B Feb/2026
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 145.87B 10.78B Feb/2026
PTC Therapeutics USD 4.88B 1B Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025
Xencor USD 837M 278M Sep/2025